Relivira
Underwear seller strips a number of marketing claims after a TINA.org inquiry.
Actos
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
The Latest
Tesla Needs to Pull the Plug on Its Deceptive Made in USA Claims
TINA.org notifies electric vehicle maker for second time in three years.
Ford, Stellantis run ad campaigns touting their American heritage to influence Trump
Jamie L. LaReau, Detroit Free Press
Wood-N-Tap
Getting hangry over a hidden delivery fee.
CATrends: Deceptive ‘Plant-Based’ Claims
A deceptive marketing trend takes root.